Dialysis water and fluid purity: More than endotoxin

Nephrology Dialysis Transplantation

Volumn 27, Issue 11, 2012, Pages 4010-4021

  Glorieux, Griet ^a   Neirynck, Nathalie ^a   Veys, Nic ^a   Vanholder, Raymond ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

approaches for action; detection methods; dialysis fluid purity; microbial contamination; purity standards

Indexed keywords

ALBUMIN; BACTERIAL DNA; C REACTIVE PROTEIN; DIALYSIS FLUID; DNA FRAGMENT; ENDOTOXIN; HEMOGLOBIN; ICODEXTRIN; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; PEPTIDOGLYCAN; TOLL LIKE RECEPTOR; WATER;

BACTERIAL COUNT; BACTERIUM CULTURE; BIOASSAY; CHRONIC KIDNEY DISEASE; DISINFECTION; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HEMODIALYSIS; HEMODIALYSIS PATIENT; HOME DIALYSIS; HUMAN; LONG TERM EXPOSURE; MICROBIAL CONTAMINATION; PERITONEAL DIALYSIS; PERITONITIS; PRIORITY JOURNAL; QUALITY CONTROL; REVERSE OSMOSIS; REVIEW; SAMPLING ERROR; STANDARD; WATER ANALYSIS; WATER QUALITY;

DIALYSIS SOLUTIONS; DRUG CONTAMINATION; ENDOTOXINS; HEMODIAFILTRATION; HUMANS; KIDNEY FAILURE, CHRONIC; RENAL DIALYSIS; WATER;

EID: 84868688427     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfs306     Document Type: Review

References (39)

1. Blankestijn PJ, Ledebo I, Canaud B. Hemodiafiltration: clinical evidence and remaining questions. Kidney Int 2010; 77:581-587.
2. Ledebo I, Blankestijn P. Haemodiafiltration-optimal efficiency and safety. Nephrol Dial Transplant Plus 2010; 3(1):8-16.
3. Cheung AK, Levin NW, Greene Tet al. Effects of high-flux hemodia-lysis on clinical outcomes: results of the HEMO study. J Am Soc Nephrol 2003; 14:3251-3263. (Pubitemid 37509301)
4. Delmez JA, Yan GF, Bailey J et al. Cerebrovascular disease in maintenance hemodialysis patients: results of the HEMO study. Am J Kidney Dis 2006; 47:131-138. (Pubitemid 41828275)
5. Locatelli F, Martin-Malo A, Hannedouche T et al. Effect of membrane permeability on survival of hemodialysis patients. J Am Soc Nephrol 2009; 20:645-654.
6. Grooteman M, Van den Dorpel R, Bots M et al. Effect of online he-modialfiltration on all-cause mortality and cardiovascular outcomes. J Am Soc Nephrol, 2012; 23(6):1087-1096.
7. Ok E, Asci G, Ok ES et al. Comparison of postdilution on-line hemo-diafiltration and hemodialysis (Turkish HDF study). XLVIII ERA-EDTA Congress Prague. 2011.
8. Bambauer R, Schauer M, Schiel R et al. Contamination of dialysis water and dialysate. A survey in 30 German centers. ASAIO J 1994; 40(4):1012-1016. (Pubitemid 24372231)
9. Gomila M, Gasco J, Gil J et al. A molecular microbial ecology approach to studying hemodialysis water and fluid. Kidney Int 2006; 70:1567-1576. (Pubitemid 44606991)
10. Abraham WR. Controlling biofilms of gram-positive pathogenic bacteria. Curr Med Chem 2006; 13:1509-1524.
11. Cappelli G, Sereni L, Scialoja MG et al. Effects of biofilm formation on haemodialysis monitor disinfection. Nephrol Dial Transplant 2003; 18:2105-2111. (Pubitemid 37220318)
12. Penne EL, Visser L, Van den Dorpel MA et al. Microbiological quality and quality control of purified water and ultrapure dialysis fluids for online hemodiafiltration in routine clinical practice. Kidney Int 2009; 76:665-672.
13. Smeets E, Kooman J, Van der Sande F et al. Prevention of biofilm formation in dialysis water treatment systems. Kidney Int 2003; 63:1574-1576. (Pubitemid 36350024)
14. Luderitz O, Tanamoto K, Galanos C et al. Structural principles of lipopolysaccharides and biological properties of synthetic partial structures. ACS Symp Ser 1983; 231:3-17.
15. Caroff M, Karibian D, Cavaillon JM et al. Structural and functional analyses of bacterial lipopolysaccharides. Microbes Infect 2002; 4:915-926. (Pubitemid 34775233)
16. Praditpornsilpa K, Tiranathanagul K, Susantitaphong P et al. Effects of different levels of endotoxin contamination on inflammatory cyto-kine production by peripheral blood mononuclear cells after high-flux hemodialysis. Blood Purif 2011; 32:112-116.
17. Glorieux G, Schepers E, Schindler R et al. A novel bio-assay increases the detection yield of microbiological impurity of dialysis fluid, in comparison to the LAL-test. Nephrol Dial Transplant 2009; 24:548-554.
18. Vanholder R, Vanhaecke E, Veys N et al. Endotoxin transfer through dialysis membranes-small-pore versus large-pore membranes. Nephrol Dial Transplant 1992; 7:333-339.
19. Barreteau H, Kovac A, Boniface A et al. Cytoplasmic steps of pepti-doglycan biosynthesis. FEMS Microbiol Rev 2008; 32:168-207.
20. Martis L, Patel M, Giertych J et al. Aseptic peritonitis due to pepti-doglycan contamination of pharmacopoeia standard dialysis solution. Lancet 2005; 365:588-594. (Pubitemid 40247915)
21. Tsuchida K, Takemoto Y, Yamagami S et al. Detection of peptido-glycan and endotoxin in dialysate, using silkworm larvae plasma and limulus amebocyte lysate methods. Nephron 1997; 75:438-443. (Pubitemid 27156738)
22. Schindler R, Beck W, Deppisch R et al. Short bacterial DNA fragments: detection in dialysate and induction of cytokines. J Am Soc Nephrol 2004; 15:3207-3214. (Pubitemid 39578853)
23. Navarro MD, Carracedo J, Ramirez R et al. Bacterial DNA prolongs the survival of inflamed mononuclear cells in haemodialysis patients. Nephrol Dial Transplant 2007; 22:3580-3585. (Pubitemid 350212484)
24. Merino A, Nogueras S, Garcia-Maceira T et al. Bacterial DNA and endothelial damage in haemodialysis patients. Nephrol Dial Transplant 2008; 23:3635-3642.
25. Bossola M, Sanguinetti M, Scribano D et al. Circulating bacterial-derived DNA fragments and markers of inflammation in chronic he-modialysis patients. Clin J Am Soc Nephrol 2009; 4:379-385.
26. Akira S, Takeda K, Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol 2001; 2:675-680. (Pubitemid 32747155)
27. Uehara A, Yang S, Fujimoto Y et al. Muramyldipeptide and diami-nopimelic acid-containing desmuramylpeptides in combination with chemically synthesized Toll-like receptor agonists synergistically induced production of interleukin-8 in a NOD2-and NOD1-depen-dent manner, respectively, in human monocytic cells in culture. Cell Microbiol 2005; 7:53-61.
28. Nystrand R. Microbiology of water and fluids for hemodialysis. J Chin Med Assoc 2008; 71:223-229. (Pubitemid 351803457)
29. AAMI Renal Disease and Detoxification Committee. Dialysate for hemodialysis. Arlington, VA: AAMI, 2004, pp. 24-27.
30. European Best Practice Guidelines-Hemodialysis. Section IV. Dialysis fluid purity. Nephrol Dial Transplant 2002; 17:45-62.
31. Quality of dialysis fluid for haemodialysis and related therapies. ISO 11663:2009(E). 2009.
32. Guidance for the preparation and quality management of fluids for haemodialysis and related therapies. ISO 23500:2011(E). 2011.
33. Button D. Life in extremely dilute environments: the major role of oligobacteria. In: Bull A (ed). Microbial Diversity and Bioprospect-ing. Washington, DC: American Society of Microbiology Press, 2004, pp. 160-168.
34. Mannoor MS, Zhang SY, Link AJ et al. Electrical detection of pathogenic bacteria via immobilized antimicrobial peptides. Proc Natl Acad Sci USA 2010; 107:19207-19212.
35. Lonnemann G. Assessment of the quality of dialysate. Nephrol Dial Transplant 1998; 13:17-20. (Pubitemid 28224869)
36. Klein E, Pass T, Harding GB et al. Microbial and endotoxin contamination in water and dialysate in the central United-States. Artif Organs 1990; 14:85-94. (Pubitemid 20140767)
37. Arizono K, Nomura K, Motoyama T et al. Use of ultrapure dialysate in reduction of chronic inflammation during hemodialysis. Blood Purif 2004; 22:26-29.
38. Sitter T, Bergner A, Schiffl H. Dialysate related cytokine induction and response to recombinant human erythropoietin in haemodialysis patients. Nephrol Dial Transplant 2000; 15:1207-1211. (Pubitemid 30487799)
39. Zimmermann J, Herrlinger S, Pruy A et al. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int 1999; 55:648-658. (Pubitemid 29082891)